Full text is available at the source.
Abstract
This plasmonic CRISPR/Cas12a platform improves detection limits by approximately 52-fold and reduces reaction time to 15 minutes.
- The system addresses challenges in detecting non-nucleic acid targets, including low sensitivity and poor reporter performance.
- Continuous regeneration of Cas12a is enabled through engineered circular DNA (cir-DNA), facilitating autocatalytic signal amplification.
- Plasmonic spherical nucleic acids enhance fluorescence signals and accelerate reaction kinetics.
- A convolutional neural network model was utilized for assessing risk levels of perfluorooctanoic acid (PFOA) from serum concentrations.
- High accuracy in blind testing was achieved, indicating potential clinical applications for pregnancy risk assessment.
Simplified